0001209191-24-001802.txt : 20240117
0001209191-24-001802.hdr.sgml : 20240117
20240117190152
ACCESSION NUMBER: 0001209191-24-001802
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240112
FILED AS OF DATE: 20240117
DATE AS OF CHANGE: 20240117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Farrell Robert E Jr
CENTRAL INDEX KEY: 0001592280
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38940
FILM NUMBER: 24539727
MAIL ADDRESS:
STREET 1: CAMBRIDGE DISCOVERY PARK
STREET 2: 100 ACORN PARK DRIVE, 5TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Morphic Holding, Inc.
CENTRAL INDEX KEY: 0001679363
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 473878772
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE A2
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781) 996-0955
MAIL ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE A2
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Morphic Holding, LLC
DATE OF NAME CHANGE: 20160712
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-01-12
0
0001679363
Morphic Holding, Inc.
MORF
0001592280
Farrell Robert E Jr
C/O MORPHIC HOLDING, INC.
35 GATEHOUSE DRIVE, A2
WALTHAM
MA
02451
0
1
0
0
SVP Finance and CAO
0
Common Stock
2024-01-13
4
M
0
12675
0.00
A
36611
D
Common Stock
2024-01-14
4
M
0
3470
0.00
A
40081
D
Common Stock
2024-01-16
4
S
0
5089
27.4907
D
34992
D
Stock Option (right to buy Common Stock)
27.79
2024-01-12
4
A
0
88800
0.00
A
2034-01-11
Common Stock
88800
88800
D
Restricted Stock Unit
2024-01-12
4
A
0
62400
0.00
A
Common Stock
62400
62400
D
Restricted Stock Unit
2024-01-13
4
M
0
12675
0.00
D
Common Stock
12675
38025
D
Restricted Stock Unit
2024-01-14
4
M
0
3470
0.00
D
Common Stock
3470
6940
D
Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
Includes 228 shares of Common Stock acquired under the issuer's employee stock purchase plan on August 31, 2023.
The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
The option vests as to 2.0833% of the total shares monthly, beginning February 12, 2024, with 100% of the total shares vested and exercisable on January 12, 2028, subject to the reporting person's provision of service to the issuer on each vesting date.
The RSUs vest as to 25% of the total shares on each of January 12, 2025, January 12, 2026, January 12, 2027 and January 12, 2028, subject to the reporting person's provision of service to the issuer on each vesting date.
The RSUs vest as to 25% of the total shares on each of January 13, 2024, January 13, 2025, January 13, 2026 and January 13, 2027, subject to the reporting person's provision of service to the issuer on each vesting date.
The RSUs vest as to 25% of the total shares on each of January 14, 2023, January 14, 2024, January 14, 2025 and January 14, 2026, subject to the reporting person's provision of service to the issuer on each vesting date.
/s/ Robert Farrell
2024-01-17